PC
CELU icon

Periscope Capital’s Celularity CELU Stock Holding History

Periscope Capital’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-49,216
Closed -$5.01M – 876
2021
Q2 		$5.01M Sell
49,216
-5,784
-11% -$586K 0.16% 264
2021
Q1 		$5.54M Sell
55,000
-73,000
-57% -$7.48M 0.22% 185
2020
Q4 		$14.1M Sell
128,000
-51,729
-29% -$5.5M 0.74% 15
2020
Q3 		$18.9M Buy
179,729
+69,580
+63% +$7.21M 1.31% 6
2020
Q2 		$11.2M Buy
110,149
+19,969
+22% +$1.98M 1.01% 21
2020
Q1 		$8.84M Buy
90,180
+35,000
+63% +$3.46M 1.07% 19
2019
Q4 		$5.49M Buy
55,180
+19,980
+57% +$1.98M 0.66% 56
2019
Q3 		$3.46M Buy
+35,200
New +$3.45M 0.45% 85

Other funds holding CELU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Periscope Capital's CELU Position: Q3 2021 in Review

Periscope Capital sold out of Celularity (CELU) in Q3 2021, closing a stake of 49,216 shares — an estimated $5.01M sold.

Periscope Capital first reported a position in CELU in Q3 2019 and held it in 8 quarters. The position peaked at $18.9M in Q3 2020. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • Periscope Capital reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • Periscope Capital sold 49,216 Celularity shares in Q3 2021, an estimated $5.01M.
  • Periscope Capital first reported a position in Celularity in Q3 2019 and held it in 8 quarters.
  • Periscope Capital's Celularity position peaked at $18.9M in Q3 2020.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Periscope Capital's 13F filing for Q3 2021, filed 12 Nov 2021.